Cardiovascular risks have a detrimental impact on human health, and some research has implicated TRPM4 in cardiac hypertrophy, myocardial ischemia-reperfusion injury (IRI), and hereditary arrhythmia [16,17,18,19,20,21,22,23,24]. Here, TRPM4 is linked to cardiac hypertrophy.